Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds eukaryotic cell or component thereof or substance...
Patent
1997-02-28
1999-10-05
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds eukaryotic cell or component thereof or substance...
4241541, 53038875, 5303896, A61K 39395, C07K 1628
Patent
active
059619767
ABSTRACT:
This invention is directed to monoclonal antibodies produced by using CD4-expressing T lymphocytes, such as peripheral blood mononuclear T cells, thymocytes, splenocytes and leukemia or lymphoma derived T cell line cells such as HPB-ALL or SUP-T as the immunogen in accordance with the protocols and screening procedures described. The monoclonal antibodies of the present invention are characterized by their ability to neutralize in vitro and in vivo primary isolates of Human Immunodeficiency Virus (HIV) and related immunodeficiency viruses. The antibodies are directed against a host cell antigen complex comprising CD4 protein in association with domains from chemokine receptors and have broad neutralizing activities against primary isolates from all clades of HIV type 1 (HIV-1) and primary isolates of HIV type 2 (HIV-2) and Simian Immunodeficiency Virus (SIV). The present invention is also directed to a method of selecting and producing such antibodies, hybridomas which secrete such antibodies, pharmaceutical compositions comprising such antibodies and methods for pre- and post-exposure prevention of immunodeficiency virus infection in primates, including humans, by such antibodies whose primary targets are CD4 expressing lymphocytes.
REFERENCES:
patent: 4381295 (1983-04-01), Kung et al.
patent: 4816397 (1989-03-01), Boss et al.
patent: 5171838 (1992-12-01), Chiba
Arthos et al., (1989) "Identification of the Residues in Human CD4 Critical for the Binding of HIV" Cells 57:469-481.
Arthur et al., (1991) "Cellular Proteins Bound to Immunodeficiency Viruses: Implications for Pathogenesis and Vaccines" Science 258:1935-1938.
Attanasio et al. (1993) "Monoclonal Anti-CD4 as Immunoprophylactic Agents for Human Immunodeficiency Virus Infection" J. Infect. Dis. 168:515-516.
Baltimore (1995) "The Enigma of HIV Infection" Cell 82:175-176.
Belshe et al. (1994) "Neutralizing Antibodies to HIV-1 in Seronegative Volunteers Immunized with Recombinant gp120 from the MN Strain of HIV-1" JAMA 272;475-480.
Brady et al. (1993) "Crystal Structure of Domains 3 and 4 of Rat CD4: Relation to the NH.sub.2 --Terminal Domains" Science 260:979-983.
Burkly et al. (1992) "Inhibition of HIV Infection by a Novel CD4 Domain 2-Specific Monoclonal Antibody" J. Immunol. 149:1779-1787.
Burton et al. (1994) "Effective Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody" Science 266:1024-1027.
Budens Robert D.
United Biomedical Inc.
LandOfFree
Antibodies against a host cell antigen complex for pre- and post does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against a host cell antigen complex for pre- and post, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against a host cell antigen complex for pre- and post will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1168349